The Chief Psychiatrist has taken the following actions in the best interests of the Western Australian community in keeping with recommended procedures to limit the spread of COVID-19. Clinical Helpdesk…
Print this page
Latest news
WA Seclusion and Restraint Data: Quarters 1&2 2019-2020
26 Mar 2020
The Chief Psychiatrist is committed to reducing the rate of restrictive practices, seclusion and restraint, in Western Australia (WA). In order to promote transparency in the use of restrictive practices…
Out and About with the Chief Psychiatrist – Pilbara
19 Feb 2020
Recently the Chief Psychiatrist, Dr Nathan Gibson and Ms Cate Wray, Consultant, Statutory Authorisations and Approvals visited the Pilbara Region. Dr Gibson and Ms Wray were accompanied by Dr Roland…
Resource and training opportunity for clinicians engaging with carers
5 Feb 2020
The Chief Psychiatrist wishes to share information about an important resource and training opportunity for engaging with the family and friends (carers) of people experiencing mental health issues. The “Practical Guide…
From Death We Learn 2018
30 Dec 2019
The WA Department of Health’s Patient Safety Surveillance Unit has just released From Death We Learn 2018. This annual publication seeks to promote education and improve awareness across the WA…
WA Seclusion and Restraint Data 2018-2019
16 Dec 2019
The Chief Psychiatrist is committed to reducing the rate of restrictive practices, seclusion and restraint, in Western Australia (WA). Nationally, WA has been a leader in reducing the rates of…
Chief Psychiatrist’s Sexual Safety Guidelines: Draft for consultation
9 Dec 2019
The Office of the Chief Psychiatrist has been developing guidelines for the sexual safety of consumers of mental health services, and our reference group has produced a draft for wider…
Mental Health Drug Bulletin: Clozapine induced Gastrointestinal Hypomotility
28 Nov 2019
The latest edition of the Mental Health Drug Bulletin has been published and focuses on clozapine-induced gastrointestinal hypomobility. Clozapine is considered the ‘gold standard’ medication for the treatment of schizophrenia,…
Antipsychotic Switching Tool – NPS MedicineWise
11 Nov 2019
NPS MedicineWise has published an updated Antipsychotic Switching Tool. This tool aims to assist prescribers when changing a patient’s antipsychotic treatment. Access the tool here
Draft Discussion Paper – People with Serious Mental Illness and Challenging Behaviours
22 Oct 2019
HAVE YOUR SAY! The Chief Psychiatrist has been increasingly concerned about the standard of care being provided to people with serious, enduring mental illness and challenging behaviours. Both clinicians and…